Evidence map›Paper›PMID 42065783›Full record

ArticleAnalytical and bioanalytical chemistry2026

A label-free colorimetric strategy for acid phosphatase detection based on in-situ Pd nanozyme formation and smartphone analysis.

Nancheng Lian, Gengneng Lai, Ran Ge, Xiuzhi Xu, Fang Ke, Changsheng Wang

Abstract read
PubMed Publisher
In one paragraph

Article in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nancheng LianDepartment of Spinal Surgery, First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, China.
Gengneng LaiSchool of Pharmacy, Institute of Materia Medica, Fujian Provincial Key Laboratory of Natural Medicine Pharmacology, Fujian Medical University, Fuzhou, 350004, China.
Ran GeDepartment of Nuclear Medicine, Fujian Medical University Union Hospital, Fuzhou, 350001, China.
Xiuzhi XuSchool of Pharmacy, Institute of Materia Medica, Fujian Provincial Key Laboratory of Natural Medicine Pharmacology, Fujian Medical University, Fuzhou, 350004, China.
Fang KeSchool of Pharmacy, Institute of Materia Medica, Fujian Provincial Key Laboratory of Natural Medicine Pharmacology, Fujian Medical University, Fuzhou, 350004, China. kefang@mail.fjmu.edu.cn.
Changsheng WangDepartment of Spinal Surgery, First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, China. wangcs0583@126.com.

Funding

Fujian Provincial Key Laboratory of Hepatic Drug Research No. KFLX2024002Natural Science Foundation of Fujian Province 2025J01708Natural Science Foundation of Fujian Province Nos. 2025J01702
6 · The paper itself

Abstract

Acid phosphatase (ACP) is a critical biomarker for prostate cancer prognosis, but conventional detection methods often lack sensitivity and portability. We report a label-free colorimetric platform for ACP detection that integrates in-situ Pd nanozyme synthesis with smartphone-based analysis. ACP hydrolyzes L-ascorbic acid 2-phosphate sesquimagnesium (AAPS) to generate ascorbic acid (AA), which reduces Pd

Indexed as

Acid PhosphataseColorimetryMetal NanoparticlesPalladiumSmartphoneAscorbic AcidHumansHydrogen PeroxideLimit of DetectionAcid PhosphataseAscorbic AcidHydrogen PeroxidePalladiumACPColorimetric assayPd NPsPeroxidaseSmartphone detection

Identifiers

PMID42065783

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.